Skip to content

The Effect of Two Different Massages on Migraine

Comparison of the Effectiveness of Connective Tissue Massage and Classical Massage in Patients With Migraine

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05452330
Enrollment
30
Registered
2022-07-11
Start date
2022-07-18
Completion date
2022-09-16
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache, Migraine, Manuel Therapy

Brief summary

The study aims to compare the effects of connective tissue massage on pain severity, attack frequency and duration, migraine-related disability, and quality of life in patients diagnosed with migraine, by comparing them with the classical massage.

Interventions

Connective tissue massage will be applied with short and long pulling strokes to create a reflex effect for 2 days a week, a total of 8 weeks.

Classical massage will be applied with the techniques of stroking, kneading, and friction for 2 days a week, a total of 8 weeks.

Sponsors

Biruni University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Volunteers with a migraine diagnosis * Taking only analgesics for migraine treatment and continuing their routines * No problem in reading, writing and understanding Turkish

Exclusion criteria

* Having any other neurological problems * Who had been injected with botulinum toxin in the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensity8 weeksThe intensity of pain perceived by the subjects will be evaluated with a valid method, the Visual Analogue Scale (VAS). The higher numbers show higher pain intensities.

Secondary

MeasureTime frameDescription
Migraine Related Disability8 weeksThe Migraine Disability Assessment Scale (MIDAS), which is considered valid and reliable, will be used to evaluate the migraine-related disability. The higher scores indicate an increase in the severity of the disability.
The Quality of Life8 weeksThe patients' quality of life will be evaluated with the 24-hours Quality of Life in Migraine Scale (24-Hr-MQoLQ), which is valid and reliable. The increase in the score obtained from the scale indicates an increase in the quality of life.
Perceived Patient-Reported Change8th week (one week)The change perceived by the patients after the intervention will be evaluated with the Global Rating of Change Scale (GROC). According to the scale, it is expressed as -2: I am much worse, -1: I am worse, 0: No change, 1: I am better, 2: I am much better.
The general descriptive demographic information8 weeksThe general descriptive demographic information of the participants such as age and gender; migraine family history, duration of the complaints, attack frequency and duration will be questioned with a form prepared by the researchers.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026